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Large-scale Discovery of substrates 
of the Human Kinome
Naoyuki sugiyama  , Haruna Imamura & Yasushi Ishihama  
Kinase networks are important for cellular signal transduction. Despite tremendous efforts to uncover 
these signaling pathways, huge numbers of uncharacterized phosphosites still remain in the human 
proteome. Because of the transient nature of kinase-substrate interactions in vivo, it is almost 
impossible to identify direct substrates. Here, we present a strategy for the rapid, accurate and high-
throughput discovery of in vitro kinase substrates using quantitative proteomics. Using 385 purified 
kinases (354 wild-type protein kinases, 21 mutants and 10 lipid kinases), we identified a total of 175,574 
potential direct kinase substrates. In addition, we identified novel kinase groups, such as one group 
containing 30 threonine-directed kinases and another containing 15 serine/threonine/tyrosine kinases. 
surprisingly, we observed that the diversity of substrates for tyrosine kinases was much higher than 
that for serine-threonine kinases.
Reversible protein phosphorylation catalyzed by both protein kinases and phosphatases plays essential roles in 
cellular signal transduction that controls a variety of cellular functions1. Based on the results from human genome 
project, at least 518 protein kinases are considered to be encoded in human genome2, and at least 70% of all human 
proteins are phosphorylated by these kinases3,4. This indicates that each protein kinase involves roughly hundreds 
of phosphorylation events, and the phosphorylation network formed by them must be extremely complicated.
It is well known that kinase-mediated phosphorylation signals are involved in various diseases such as can-
cer, and often cause the disease itself or drive its progression. Large-scale cancer genome sequencing projects 
have been conducted to detect mutationally activated proteins, including kinases, in cancer signaling path-
ways5, and inhibitors of oncogenic kinases have been extensively developed for cancer therapy since the success 
of imatinib for Bcr-Abl-positive chronic myeloid leukemia (CML) patients. However, although genomics- and 
proteomics-based approaches have been applied to characterize kinases6–8, we still lack basic information on 
many kinases, such as their substrates, phosphorylation motifs and molecular functions, and more information 
is required to unveil the entire network of protein phosphorylation.
In recent years, mass spectrometry (MS)-based phosphoproteomics have been improved, especially phospho-
peptide enrichment approaches, such as immunoprecipitation with anti-phosphotyrosine antibodies9, immo-
bilized metal ion affinity chromatography (IMAC)10,11 and metal oxide chromatography with enhancers12–15. 
Many biological applications of these technologies have been reported, e.g., to study the signal transduction of 
epidermal growth factor16, cell cycle regulation3,17, embryonic stem cell differentiation18 and tissue-specific phos-
phorylation events19, resulting in the identification/quantification of tens of thousands of phosphosites. Thus far, 
over 100,000 phosphosites in the human proteome have been registered in public databases such as UniProtKB20, 
PhosphoELM21, PhosphoSitePlus22, PHOSIDA23 and HPRD24. Although recent advances in MS-based phosphop-
roteomics have enabled identification of more than 10,000 sites by a single LC/MS/MS measurement25, the nature 
of the exact kinases responsible for these sites largely remains to be elucidated. Moreover, even at the protein level, 
less than 40% of phosphoproteins can be mapped to the KEGG pathway database26, and the functional roles of the 
phosphorylated sites are still unclear in many cases27.
It is considered that in general each kinase prefers to phosphorylate the substrates with particular sequence, 
namely, a phosphorylation motif, which often has been utilized for in silico prediction of kinase-substrate rela-
tionships. On the basis of limited dataset of in vitro kinase assay, various computational tools for prediction of 
responsible kinases or potential substrates, such as Scansite28 and NetPhorest29, have been developed to date. In 
some cases, public datasets on protein-protein interaction have been integrated in some computational tools for 
kinase prediction from queried phosphosites30–32. Many in silico prediction tools for kinase-substrate relation-
ships have been developed32,33, however, a bottleneck in these tools is the absence of a sufficient experimental 
kinase-substrate dataset to provide phosphorylation motifs of an individual protein kinase.
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Recently, peptide arrays using a synthetic peptide library with randomized sequences34 or a position scanning 
peptide library35 have been employed to extract phosphorylation motifs rapidly36–38. Mok et al. have reported 
large-scale analysis of yeast phosphorylation motifs using peptide library screening and identified motifs for 61 
kinases39. Newman et al. have reported 300 phosphorylation motifs for 289 kinases by in vitro kinase profiling 
using a protein array, although phosphosites were not experimentally identified40. These array-based approaches 
allow a high-throughput profiling of substrate preference for each kinase in a large scale. Regarding MS-based 
approaches with a biological sample as a substrate source, Huang et al. identified PKA and PKG substrates from 
rat uteri by using an in vitro kinase assay followed by a phosphoproteomics approach41; 61 and 12 in vitro sub-
strates as well as consensus phosphorylation motifs were found for PKA and PKG, respectively, and found that 
some of the in vitro substrates were potential physiological substrates. Zhang et al. also reported a solid-phase 
approach for the identification of in vitro CK2 substrates using immobilized proteins from a cell extract as a 
substrate source42, and suggested the method may reduce effects of intrinsic active kinases compared with 
solution-based approach. Kettenbach et al.43 and Douglas et al.44 investigated in vitro kinase substrates using 
digested peptides from a cell lysate as a substrate source and identified hundreds to thousands of in vitro sub-
strates of each kinase. Furthermore combination use of in vitro assay and in vivo phosphoproteome analysis was 
utilized to identify physiologically relevant substrates45,46. MS-based in vitro kinase assays became a powerful tool, 
nevertheless the total number of human kinases employed thus far in the individual study is still quite limited 
(less than 15).
Previously, we developed an LC-MS/MS-based in vitro kinase assay to profile three human protein kinases, 
Erk1, AKT1 and PKA, in which dephosphorylated lysate proteins were used as the substrate source for in 
vitro kinase reaction and the phosphorylated proteins were digested by trypsin, fractionated by ion-exchange 
StageTip, enriched by titania chromatography and analyzed by LC-MS/MS47. Thousands of in vitro phospho-
rylation sites for each kinase were successfully identified and several new phosphorylation motifs together 
with the known motifs reflecting the specificity of each kinase were found. In this study, we modified the pre-
vious approach for kinome-wide applications, in which a stable isotope-based quantitation approach was used 
through the study to reject the endogenously phosphorylated proteins remaining in the substrate source even 
after phosphatase-treatment. By using this approach, 385 human recombinant kinases consisting of 354 wild-type 
protein kinases, 21 mutants and 10 lipid kinases were analyzed to acquire an in vitro substrate library as well as 
phosphorylation motifs. Substrate preference of each kinase was more accurately obtained by using quantitative 
phosphoproteomic approach with an isotopical labeling to reject the contaminant phosphoproteins constantly 
through this study. Using these results, a novel ‘kinome tree’ based on kinase-substrate relationships was proposed.
Results
Large-scale identification of in vitro kinase substrates. Using dephosphorylated HeLa cell lysate as 
the substrate source, 385 kinds of recombinant human protein kinases were individually employed for an in vitro 
kinase assay (Fig. 1). Prior to the kinase assay, we examined the dephosphorylation efficiency of thermo-sensitive 
alkaline phosphatase (TSAP). As shown in Supplementary Fig. S1, most of the phosphosites were dephospho-
rylated at an efficiency of over 95%. However, a small population of phosphosites was not effectively dephos-
phorylated by TSAP, indicating that it is necessary to quantify the residual phosphopeptides to identify kinase 
substrates accurately. In this study, chemical dimethyl labeling of peptide amino groups48 was carried out with 
exactly the same materials used for kinase-treated and control samples after cell lysis and TSAP dephosphoryla-
tion (Supplementary Fig. S1). We used a peptide peak area ratio of kinase-treated to control as an acceptance cri-
terion for determining kinase substrate, where the ratio should be more than 2. False-positive substrates derived 
from inherent phosphopeptides which were not able to be dephosphorylated by TSAP were successfully rejected 
by using the quantitative analysis with the isotopic labeling.
A reproducibility of in vitro kinase assay was evaluated by comparison between biological and technical trip-
licates (Supplementary Fig. S2). Distribution of overlaps of identified phosphopeptides between each pair of 
biological replicates was similar to that observed in technical replicates. Note that a reproducibility of quanti-
fication with dimethyl labeling was also confirmed by RSD of the peak area ratio of kinase-treated to control 
(9.5 ± 15.8% in biological triplicates).Activities of endogenous protein kinases in the cell lysate were estimated 
by selected reaction monitoring (SRM) of kinase-activity targeted phosphopeptides49. Phosphorylation levels of 
activity-regulatory sites of the kinases belong to EGFR-MAPK pathway were not significantly changed by spiking 
recombinant EGFR (Supplementary Fig. S3). This result suggested that endogenous kinases were not activated by 
a spiked recombinant kinase during the in vitro assay.
An in vitro kinase assay was performed for 354 wild-type recombinant kinases. In total, 29,837 non-redundant 
phosphosites were identified. The use of the quantitative criteria mentioned above left 20,669 reliable phos-
phosites, based on 175,574 kinase-substrate pairs (Table 1, Supplementary Tables S1 and S2). There were 9,998 
phosphorylated serine (pS), 4,698 phosphorylated threonine (pT) and 5,973 phosphorylated tyrosine (pY) res-
idues in total. The average number of substrates per kinase was 201 serines (66%), 85 threonines (28%) and 
18 tyrosines (6%) for serine/threonine protein kinases (STKs) and 64 serines (6%), 44 threonines (4%) and 
1,036 tyrosines (91%) for tyrosine protein kinases (TKs) (Fig. 2). The high selectivity in amino acid recognition 
suggested that most of the identified substrates were directly phosphorylated with a spiked kinase rather than 
an endogenous kinase activated by the spiked one. In this study, most of the endogenous kinases should have 
been inactivated by TSAP dephosphorylation and/or heat denaturation before the kinase reaction. In addition, 
subcellular localization and protein complexes were corrupted during cell lysis and denaturation. Further, the 
concentrations of the kinases and substrates were highly diluted relative to the concentrations under physio-
logical conditions. Therefore, it is unlikely that secondary reactions with endogenous kinase(s) activated by the 
spiked recombinant kinase occurred under our conditions as evaluated by monitoring activities of endogenous 
kinases (Supplementary Fig. S3). The possibility of autophosphorylation or phosphorylation by constitutively 
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active kinases was ruled out by applying the criteria shown in Supplementary Fig. S1. A small percentage of pY 
was identified in the assay for STKs, and pS and pT were identified for TKs, even after more stringent filtering 
based on PTM scores16 (See Supplementary Table S1). This is presumably because the amino acid preferences of 
STKs and TKs are not highly exclusive under in vitro conditions. Kettenbach et al. recently reported that Haspin 
showed slight tyrosine-phosphorylation activity in an in vitro assay using motif-containing synthetic peptides, 
suggesting that slightly phosphorylated tyrosines of abundant proteins might be detectable as STK substrates. 
Another reason is that a portion of the phosphorylated tyrosines were derived from spiked STKs themselves, 
and these had been prepared as commercial products to maximize their kinase activity. The phosphorylation 
statuses of the tested kinases were investigated individually by LC-MS analysis of their tryptic digests. We found 
that 87% of the tested TKs and 23% of the STKs had at least one phosphorylated serine/threonine and tyrosine, 
respectively. In addition, it is still difficult to correctly determine phosphosite localization from incompletely 
fragmented MS/MS spectra, even though some probability-based scoring methods for site determination, such 
as Ascore50 and PTM score, have been developed.
Figure 1. Overview of in vitro kinase profiling. HeLa cell lysate was dephosphorylated with alkaline 
phosphatase, and spiked phosphatase was inactivated with heat. Small aliquots of the dephosphorylated lysate 
were reacted with recombinant protein kinase. The mock-reacted sample was used as a control. After tryptic 
digestion, both samples were labeled with heavy or light formaldehyde. Phosphopeptides enriched with titania-
HAMMOC14 were analyzed with nanoLC-MS.
Number of phosphositesa
pS/T/Y pS pT pY
All kinases 175,574 59,945 26,724 88,905
STKs 83,018 54,945 23,160 4,913
TKs 92,556 5,000 3,564 83,992
Unique phosphosites 20,669 9,998 4,698 5,973
Table 1. In vitro kinase substrates for 354 wild-type human protein kinases. aThe phosphosites were obtained 
from identified phosphopeptides that satisfied quantitative criteria, i.e., a peak area ratio of more than 2.
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Identification of phosphorylation motifs. Based on the in vitro substrate source consisting of 175,574 
substrates with 354 wild-type protein kinases, phosphorylation motifs for individual TKs or STKs were extracted 
using motif-x51. By merging the data for all kinases, we obtained a total of 1,427 phosphorylation motifs targeted 
by 289 kinases (See Supplementary Table S3). To our knowledge, this is the largest list of motif-kinase relation-
ships reported so far. Most of the extracted phosphorylation motifs were not structurally rigid. The maximum 
number of fixed amino acids, including phosphorylated S/T/Y, in the extracted phosphorylation motifs was 4, 
and the numbers of phosphorylation motifs consisting of 2, 3 and 4 fixed amino acids were 1,219 (85.4%), 204 
(14.3%) and 4 (0.3%), respectively. On average, 4.12 and 7.28 phosphorylation motifs were extracted per STK 
and TK, respectively. The STK motifs could be categorized into four groups, i.e., hydrophobic, basic, acidic and 
proline-rich motifs. Among 881 phosphorylation motifs of STKs, 227 motifs contained at least one acidic amino 
acid, 349 motifs contained a basic amino acid, and 110 motifs contained proline. The average fold-increase value, 
calculated from foreground and background hits by motif-x as a measure of the significance of the extracted 
motif51, was 11.07 for STK motifs. Meanwhile, the phosphorylation motifs of most TKs were acidic amino 
acid-rich. Among 546 phosphorylation motifs of TKs, 459 motifs contained acidic amino acids, and there was 
no proline-containing motif. Most tyrosine kinases showed low specificity, as indicated by the low averaged 
fold-increase for TK motifs (2.46).
Typical examples of extracted phosphorylation motifs are shown in Fig. 3. The kinases in the CMGC group, 
which mainly included cyclin-dependent kinases (CDK) and mitogen-activated protein kinases (MAPK), had 
pS/T-P-containing motifs, like Erk1. From the CAMK group (calmodulin–regulated kinases) and AGC group 
(consisting of cyclic-nucleotide and calcium-phospholipid-dependent kinases, ribosomal S6 kinases and 
G-protein-coupled kinases), basic amino acid-rich motifs were obtained, as seen in the Akt1, MAPKAPK2 and 
NDR1 motifs. Usually, arginine and lysine appeared in the motif sequences for CAMK and AGC, although the 
motifs of the NDR and LATS families contained a histidine residue at the −5 position, as previously reported52. 
The casein kinase 1 (CK1) and 2 (CK2) families and some other kinases showed phosphorylation of peptides 
containing D/E-rich motifs.
Some protein kinases showed ‘unreported’ phosphorylation motifs that are different from already-known 
motifs (Fig. 3(b)), for example, Erk1, 2 and 5 phosphorylated sites containing alanine at the +1 position as well 
as the known motifs P-X-p(S/T)-P and p(S/T)-P. In the case of dual-specificity MAP2Ks, the known phospho-
rylation motif pT-X-pY was not extracted, although single phosphorylation of pT-X-Y-containing peptides was 
observed. The most common sequence observed in phosphorylation motifs of the MAP2K series was R-X-X-pS-P, 
which was also found to be a major phosphorylation motif of the dual-specificity kinases of the DYRK family.
Profiling of mutant protein kinases and lipid kinases. The in vitro substrates of 21 tumor-associated 
mutant protein kinases and 10 lipid kinases (LKs) were also investigated in the same manner as described for 
the wild-type kinases. Tested LKs phosphorylated few proteinous substrates, and no significant phosphorylation 
motifs could be extracted (See Supplementary Tables S1 and S2).
In general, extracted phosphorylation motifs of mutant kinases were similar to those of wild-type kinases, 
though the MET mutant Y1235D had a different phosphorylation motif, pY-X-X-R (Fig. 3(c)). Considering 
that the number of substrates phosphorylated by wild-type MET was approximately 3 times higher than that of 
the Y1235D mutant, the Y1235D mutant showed weaker kinase activity than wild-type MET, as reported53,54. 
Although 74% of the substrates targeted by the mutant were also phosphorylated by wild-type MET, more than 
half of the mutant-specific substrates had leucine, isoleucine, valine or phenylalanine at the +3 position. The 
Y1235D mutant showed a significantly different specificity, given that only approximately 30% of substrates phos-
phorylated by wild-type MET had such a hydrophobic amino acid at the +3 position.
Determination of phosphorylation stoichiometry. Phosphorylation stoichiometry or occu-
pancy of the in vitro kinase reaction was determined by measuring phosphopeptides and the corresponding 
non-phosphopeptides. As a test sample, we investigated the phosphorylation stoichiometry of each substrate 
peptide for the serine/threonine protein kinase p38γ and tyrosine kinase EPHA1 to confirm the significance 
of the phosphorylation motifs (Fig. 3(d)). There were two populations in the distribution of phosphorylation 
Figure 2. pS/T/Y distribution of in vitro substrates for STK and TK. Phosphorylated STY ratios are indicated 
for 354 wild-type human protein kinases, including 81 TKs and 273 STKs. The blue, green and yellow bars 
represent pS, pT and pY, respectively. Phosphosites were confirmed by (a) the presence of site-determining ions 
or (b) localization probability P > 0.75 based on PTM score.
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stoichiometry for both kinases. The peptides that were phosphorylated at a high rate by p38γ almost exclusively 
contained pS-P or pT-P, which were identified as phosphorylation motifs by the in vitro assay and are known 
consensus motifs of MAP kinases, although not all pS/T-P-containing peptides were phosphorylated with high 
stoichiometry. In the case of EPHA1, phosphopeptides containing the motif pY-E tended to have higher phospho-
rylation relative to peptides lacking pY-E peptides, although the distribution was not exclusive (Fig. 3(e)). These 
results indicated that the phosphorylation stoichiometry somehow reflected the specificity of kinases and their 
phosphorylation motifs, but it is difficult to use the significance or fold-change to estimate the phosphorylation 
stoichiometry.
Classification of kinases based on substrate peptides. Using the information about the in vitro sub-
strates at the site level, we performed hierarchical cluster analysis of STKs to classify the kinases and to extract 
shared phosphorylation motifs (Fig. 4(a)). They were mainly separated into three clusters, of which one was STKs 
that had pS/T-P-containing motifs (Cluster 1). Cluster 1 consisted of most of the CMGC group, except for casein 
kinase, and MAP2K and MAP3K. The second cluster consisted of multiple groups, mainly containing STE, TKL, 
CK1 and Others (Cluster 2). Furthermore this cluster could be separated into two small clusters; i.e., STKs with 
threonine specificity or D/E-rich phosphorylation motifs. The STKs belonging to the third cluster, including 
mainly the AGC and CAMK groups, had phosphorylation motifs that were basic amino acid-rich or contained 
a hydrophobic amino at the +4 position (Cluster 3). Although some common structures, such as R-X-X-pS 
or pS/T-P, were extracted as major phosphorylation motifs for many STKs in the motif analysis, the kinases 
were subdivided into small groups like families or subfamilies by the cluster analysis. This result indicates that 
the representative phosphorylation motif for each kinase is insufficient to describe kinase profiles precisely, and 
substrate-based classification has more power to distinguish subtle differences between kinases, even though the 
substrates were acquired under in vitro conditions. Conventional kinase classification (the so-called kinome tree) 
is based on sequence and domain similarity and cellular function of kinases2. The substrate-based classification 
Figure 3. Selected phosphorylation motifs found in this study. (a) Known and (b) unreported phosphorylation 
motifs extracted by motif-x with a significant score from the in vitro kinase substrates (see Supplementary 
Table S3 for all motifs covering 306 kinases, 12 families and 5 clusters). (c) Amino acid frequency in specific 
substrates for wild-type or Y1235D mutant of MET. These logos were generated by using Weblogo74. 
(d,e) Correlation between phosphorylation motif and phosphorylation stoichiometry. Phosphorylation 
stoichiometry was obtained from the peak area ratio of the corresponding dephosphorylated sample after in 
vitro kinase reaction with (d) p38γ and (e) EPHA1 (as described in Supplementary Information).
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pattern in our study was, in general, similar to the conventional kinome tree, especially in the CMGC, AGC, 
CAMK and CK1 groups. However, some clear differences were observed between the classifications, such as the 
difference in phosphorylation preference for serine, threonine and tyrosine. STKs with tyrosine preference are 
marked with # in Fig. 4(a). The phosphorylation motif G-pY was extracted from LIMK1 products, and G-X-pY 
and S-X-pY were extracted from WEE products. These phosphorylation motifs differ from those extracted from 
TK products. In total, 15 STKs were selected as Tyr-directed kinases (listed in Supplementary Table S4), although 
some kinases such as TAK1, MOS and STLK3 show Ser/Thr/Tyr triple kinase activity. It is believed that most 
STKs have Ser preference rather than Thr preference, considering that the Ser/Thr ratio in the phosphoforms 
(5/1) is higher than that in proteins (3/2)55. Recently, it was reported that Haspin and Camkk2b showed an in 
vitro Thr preference with synthetic and HeLa tryptic peptides43. In our in vitro experiments, most STKs were 
Figure 4. Classification of serine/threonine kinases based on in vitro substrates. A phylogenic kinome tree 
based on the cluster analysis. The background color of the kinase name indicates the reported kinase group2 
(see Supplementary Fig. S4 for TKs data). The threonine-specific kinases, i.e., those for which more than 50% 
of the substrate sites contain threonine, are indicated by asterisks (*). The kinases indicated by sharps (#) also 
phosphorylated tyrosine residues at a rate of more than 20% of their total substrates. The bars indicate (a) the 
number of serines/threonines/tyrosines or (b) the ratio of multiply phosphorylated peptides identified in each 
in vitro kinase profiling. The maximum ratio of multiply phosphorylated peptides (observed in TTBK1) is 0.39.
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strongly directed to Ser as expected, but MAPK, CDK and some kinases had a relatively low Ser preference. 
Furthermore, most of the STE group and a portion of the kinases belonging to the TKL and Others groups prefer-
entially phosphorylated Thr (Fig. 4 and Supplementary Table S4). This is the first report to describe kinome-level 
profiling of the serine/threonine preference of STKs, as far as we know. Interestingly, the phosphorylation motifs 
of threonine-selective kinases were less significant than the pT-containing motifs of other STKs (Fig. 5(a)). These 
results suggested that threonine-directed kinases show lower specificity than serine-directed kinases in terms 
of amino acid sequence recognition. In addition, threonine-directed kinases prefer multiple phosphorylation 
more than serine-directed kinases and tyrosine kinases (Fig. 5(b)). Recently, a correlation between kinase Ser/Thr 
specificity and the amino acid residues following the common motif “DFG” in the kinase activation loop, termed 
“DFG + 1”, was reported by Chen et al.56. The study showed that kinases with Phe and Val at the DFG + 1 position 
show serine- and threonine-directed activity, respectively. The Ser/Thr preference was changed by mutation of 
these residues. They analyzed the Ser/Thr preference of 56 STKs from S. cerevisiae and found Ser-directed kinases 
have larger hydrophobic residues (Leu, Phe, and Met) at the DFG + 1 position, whereas Thr-directed kinases have 
branched aliphatic residues (Ile, Val). They also reported that kinases without any Ser/Thr preference have Leu 
or Ser at the DFG + 1. Our results based on 255 human STKs also supported their finding that all of the kinases 
with Phe at the DFG + 1 position showed Ser preference (Fig. 5(c)). Kinases with Met at DFG + 1 were also 
serine-directed, but their Ser preference was slightly weaker than that of the kinases with Phe at the DFG + 1. 
Kinases with Val at this position exclusively showed Thr preference. By contrast, there was no stringent rule for 
kinases with other amino acids at DFG + 1. The dominant group, encompassing approximately 40% of test STKs 
and consisting of both Ser- and Thr-directed kinases, have Leu at DFG + 1. Unlike the 56 yeast kinases, most of 
the human kinases with Ser at the DFG + 1 showed a weak Ser preference but not exclusively. The human kinases 
with Ile at the DFG + 1 showed a wide range of Ser/Thr preference, whereas Thr preference was observed in the 
yeast study.
The in vitro kinase assay data for TKs was subjected to cluster analysis in the same manner as that performed 
for STKs (Supplementary Fig. S4). The clustering was strongly influenced by the number of in vitro substrates 
due to the less-specific phosphorylation motifs relative to STKs. The TKs were grouped into three major clusters, 
and some kinase families had similar or common phosphorylation motifs. However, no additional motifs were 
extracted based on shared substrates.
Figure 5. Characteristics of serine or threonine-directed kinases. (a) Correlation between serine/threonine 
preference of STKs and the maximum fold-increase in their phosphorylation motifs. (b) The box plot of a 
ratio of multiply phosphorylated peptides identified by in vitro kinase profiling for serine-directed, threonine-
directed tyrosine kinases. (c) Relationship between Ser/Thr specificity and the amino acid at the +1 position of 
the common sequence “DFG” in the kinase domains.
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Discussion
Since TSAP dephosphorylation is not complete, it is important to quantify residual phosphopeptides relative to 
peptides phosphorylated by spiked kinases. By removing residual phosphopeptides based on the relative ratio, the 
peptide sequences could be used with high confidence for motif extraction. Nevertheless, the phosphorylation 
position within the peptide sequence should be independently considered because the fragmentation of phos-
phopeptides is not always sufficient for unambiguous determination of the phosphosite. In this study, we used 
two approaches, i.e., verification of the presence of site-determining ions and probability-based scoring using 
the PTM score. Although the latter method provided more stringent results, we must consider the biases caused 
by probability-based scoring due to the difficulty in determining phosphosite localization when MS/MS spec-
tra contain more than one positional isomer of phosphopeptides. For this reason, we used the results obtained 
by the former method called site-determining ion combination (SIDIC) method57, in which phosphopeptides 
with different localization of phospho-group can be accepted when the spectrum contains different series of 
site-determining ions for each phosphosite.
Regarding the differences between proteins and peptides as substrate sources for in vitro kinase assays, it was 
reported that Haspin and Bmpr2 preferentially phosphorylate the N- or C-terminal positions of synthetic and 
HeLa tryptic peptides43. However, no such preference was observed in our study, in which proteins extracted from 
cell lysates were used as the substrate source, suggesting that peptides are not suitable as a substrate source for the 
extraction of phosphorylation motifs in some cases. In addition, tryptic cleavage may disrupt motif sequences, 
especially for basophilic motifs. Therefore, we employed proteins as the substrate source, although they were 
heat-treated to inactivate TSAP.
AMPK-related kinases including AMPKα1/β1/γ1, AMPKα2/β1/γ1, Nuak1, Nuak2, BRSK2, MELK, MARK1, 
MARK2, MARK3, MARK4, SIK and QIK were well grouped in both of the conventional kinome tree and our clas-
sification. It has been reported these kinases are regulated by phosphorylation of a T-loop Thr residue by LKB158 
as well as CAMKK259. The parent kinase LKB1 is grouped with CAMKK1, CAMKK2 and PBK in the in vitro 
assay, whereas LKB1 is not in the same group as CAMKK1, CAMKK2 and PBK in the conventional kinome tree. 
This indicates that the kinase classification based on the in vitro assay data is more reliable to predict the physi-
ological substrates in some cases. Note that the substrates commonly phosphorylated by the classified 4 kinases 
mainly contain L-X-pT or pT-X-X-G, both of which are consistent with the T-loop structure of AMPK-related 
kinases. Mapping of our classification to the classical kinome physiological tree indicates that kinases belonging 
to CMGC group, CK1 group and both of AGC and CAMK groups are exclusively proline-directed, acidophilic 
and basophilic, respectively (Supplementary Fig. S5). In contrast, both of TKL and Others groups consists of 
kinases belonging to cluster 1 and 2 in our study, and STE consists of all of clusters.
The substrate specificity of STKs was higher than that of TKs, at least in the in vitro assay, given that the num-
bers of TK substrates were generally greater than those of STK substrates and the phosphorylation motifs of TKs 
were less specific, although TKs are known to have limited number of substrates in physiological condition60. 
The results indicated kinase specificity observed by in vitro kinase profiling does not reflect their physiological 
specificity for the following reasons. First, cellular kinome has a wide dynamic range of expression level. Second, 
kinases are localized to specific subcellular compartment in general. Third, phosphatases also control phospho-
rylation level in physiological condition. In public database, the number of substrates widely vary according to 
the kinase, however it is impossible to estimate the in vivo specificity of kinase even if there is a difference in the 
number of in vitro substrates.
Although at least one specific substrate was observed for 348 out of 354 kinases in this study, there was few 
kinases which has specific consensus sequences. It means that all of the identified specific substrates are not truly 
specific, because of the random sampling nature of shotgun proteomics. Meanwhile, kinase families were well 
classified with the clustering analysis based on the in vitro substrates (Fig. 4). The result suggests that this dataset 
contain much more information rather than the simple consensus sequences. It would be possible to predict true 
kinase-specific substrates by building a computational model to characterize kinase substrate preferences61. Note 
that the synthetic peptides containing kinase-specific phosphosites can be used to determine the activities of 
protein kinases in cell lysates or tissues, based on the KAYAK strategy for instance62.
In this study, 175,574 in vitro kinase-substrate relationships including 20,669 phosphosites were identified 
by in vitro profiling of 385 human protein kinases. Among the phosphosites identified in this study, only 4,913 
phosphosites are overlapped with those obtained by ultra-deep phosphoproteome study of HeLa cells reported 
by Shrama et al.4. It is not surprising because non-physiologically relevant substrates should be observed in vitro 
due to protein denaturation of by heating process, loss of localization and high concentration of the spiked kinase. 
Additional techniques and/or information such as protein-protein interaction will enable us to more accurately 
predict physiological kinase-substrate relationships.
Although 164 other human kinases have not yet been characterized, to our knowledge, this is currently the 
largest dataset relevant to human kinase-substrate relationships. We identified more than ten times larger num-
ber of human kinase-substrate relationships than those available in the most frequently used public database 
PhosphoSitePlus (13, 726 kinase-substrate relationships for human; last modified on Nov 30, 2018), however 
our dataset covered only approximately 4% of the kinase-substrate relationships published in PhosphoSitePlus, 
regardless of whether they were observed in vivo or in vitro. In addition, overlap of kinase-substrate relation-
ships between our data and those obtained by using functional protein microarray40 is too small (Supplementary 
Fig. S6). One reason might be because our datasets were obtained only from the HeLa cell lysate as the substrate 
source. MS observability of phosphorylated peptide in this study was dependent on expression levels of substrate 
proteins in HeLa cells. Additional in vitro kinase substrate might be identified when different cell lysate is used as 
a substrate source since protein expression profiles vary among cell strains. Note that motifs obtained by in vitro 
kinase assay included all motifs extracted from known sites in PhosphosSitePlus when in vitro kinase substrates of 
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Erk1, AKT1 and PKA were deeply identified47. More comprehensive profiling would be possible with additional 
cell lines, tissues or subcellular fractionation.
In conclusion, we profiled substrate preference of the 385 human kinases using in vitro assay. This very large 
dataset of kinase-substrate pairs is expected to be a core resource in the development of more reliable computa-
tional tools to uncover the overall phosphorylation network in cells.
Methods
Materials. Titanium dioxide (titania) particle (10 μm diameter) were purchased from GL Sciences (Tokyo, 
Japan). Thermo-sensitive alkaline phosphatase (TSAP) and modified trypsin were obtained from Promega 
(Madison, WI). [2H2, 13C]Formaldehyde was purchased from ISOTEC (Miamisburg, OH). Recombinant human 
protein kinases were from Carna Biosciences (Kobe, Japan), with the exception of KHS1, SGK496, NIK, CDK6/
Cyclin D1, CDK9/Cyclin K, ALK1, CDK4/Cyclin D1, BARK1 and MPSK1 (Invitrogen, Carlsbad, CA) and 
GPRK5, FRAP, DAPK2, PKG1a, STK33, TAO1 and ULT3 (Millipore, Billerica, MA). More details on kinases 
are shown in Supplementary Table S5 and Supplementary Information. All other reagents were from WAKO 
Chemicals (Osaka, Japan).
In vitro kinase assay. HeLa cells, cultured to 80% confluence in ten 15-cm diameter dishes, were suspended 
in 10 mL of 10 mM HEPES-NaOH (pH 7.9) containing 10 mM KCl, 1.5 mM MgCl2, 0.5 mM dithiothreitol, 0.5% 
NP-40, and protease inhibitors (Sigma). After incubation for 5 min on ice, the suspension was centrifuged at 
1,500 g for 10 min, and then the buffer was exchanged with 50 mM Tris-HCl (pH 8.0) by ultrafiltration with 
BIOMAX-10K NMWL (Millipore). The amount of protein in the solution was measured with a BCA protein 
assay kit (Thermo Scientific). Thermo-sensitive alkaline phosphatase was added (10 units per mg proteins in 
lysate) to the concentrated cytoplasmic fraction. The reaction mixture was incubated at 37 °C for 60 min, and the 
phosphatase was inactivated at 75 °C for 30 min. The solution was cooled on ice for 5 min and spiked with phos-
phatase inhibitor cocktail (Sigma) according to the manufacturer’s manual. A small aliquot of the solution (4 μL) 
containing 100 μg of proteins was diluted with 16 μL of 40 mM Tris-HCl buffer (pH 7.5) containing 20 mM metal 
chloride, 1 mM ATP and some additives, as shown in Supplementary Table S5; phosphorylated with 0.5 μg of each 
protein kinase at 37 °C for 3 hours; and then heated at 95 °C for 5 min. For the control sample, 40 mM Tris-HCl 
buffer was spiked instead of kinase solution; the subsequent treatment was the same.
Digestion of the kinase-treated HeLa cell cytoplasmic fraction. After in vitro phosphorylation by 
spiked kinases, Tris-HCl buffer (pH 9.0), urea and octylglycoside were added to the supernatant at final concen-
trations of 0.1 M, 8 M and 0.4%, respectively. Reductive alkylation and digestion were performed as previously 
reported14. In brief, the solution was reduced with 10 mM dithiothreitol for 30 min at room temperature (rt), 
alkylated with 50 mM iodoacetamide for 30 min at rt in the dark and digested with Lys-C (1/100 w/w) for 3 h at 
rt, followed by dilution with 4 volumes of 50 mM ammonium bicarbonate and digestion with trypsin (1/100 w/w) 
overnight at rt. These digested samples were acidified with TFA and desalted as described below.
Desalting with an sDB-XC stagetip. Desalting using reversed phase-StageTip was performed as pre-
viously described57,63. In brief, a disk cut out from an SDB-XC Empore disk membrane (3 M) with a 10-gauge 
syringe needle was inserted into a D-1000 pipette tip (GILSON). The tip was conditioned with 100 μL of 0.1% 
TFA and 80% acetonitrile and then equilibrated with 100 μL of 0.1% TFA and 5% acetonitrile by centrifugation at 
1000 g for 1 min. The tryptic digest corresponding to 100 μg of proteins was loaded into the tip by centrifugation at 
1000 g for 5 min. The tip was washed with 100 μL of 0.1% TFA and 5% acetonitrile by centrifugation at 1000 g for 
1 min. Peptides were eluted with 100 μL of 0.1% TFA and 80% acetonitrile by centrifugation at 1000 g for 1 min.
For desalting after phosphopeptide enrichment, a disk cut out from the membrane with a 16-gauge syringe 
needle was inserted into a pipette tip D-200 (GILSON). Desalting was performed in the same manner as 
described above except that the volume of solvent and loading amount of the sample were changed. In each step, 
20 μL of solvent was used, and the whole sample eluted from one titania tip was loaded onto one desalting tip.
Dimethyl labeling with formaldehyde. Dimethyl labeling of the tryptic digest with formaldehyde was 
performed according to the literature64. The desalted tryptic digest solution was concentrated in a vacuum evap-
orator and then dissolved in 412 μL of triethylammonium bicarbonate (pH 8.0). Sixteen microliters of 4% nor-
mal and 2H2, 13C-labeled formaldehyde was added to the control and kinase-treated samples, respectively. After 
incubation for 60 min at room temperature, the reaction mixture was cooled on ice, and then 80 μL of formic acid 
was added to it. The reaction was terminated by agitation for 1 min. Both solutions were mixed, concentrated in a 
vacuum evaporator, and subjected to phosphopeptide enrichment as described below.
enrichment of phosphopeptides with metal oxide chromatography. Metal oxide chromatography 
(MOC) using titania was performed as previously described14 with slight modifications. A disk cut out from a C8 
Empore disk membrane (3 M) with a 20-gauge syringe needle was inserted into a 0.1–10 μL pipette tip (Eppendorf) 
as a frit. Then, a slurry of 0.5 mg of bulk titania beads in 10 μL of methanol was packed into the tip by centrifuga-
tion at 1000 g for 1 min. Prior to loading samples, MOC tips were equilibrated with 20 μL of 0.1% TFA and 80% 
acetonitrile with 300 mg/mL lactic acid as a selectivity enhancer (solution A) by centrifugation at 2000 g for 1 min. 
Desalted tryptic digest from a total of 100 μg of the reaction mixture was diluted with 100 μL of solution A, and 
a 50-μL aliquot was loaded onto the MOC tip four times by centrifugation at 1,000 g for 5 min. After successive 
washing with solution A and 0.1% TFA/80% acetonitrile by centrifugation at 2000 g for 1 min, the peptide was 
eluted with 50 μL of 0.5% piperidine by centrifugation at 1,000 g for 5 min. The eluted fraction was acidified with 
TFA and desalted using SDB-XC StageTips as described above. The desalted sample was concentrated in a vacuum 
evaporator, then resuspended in 10 μL of 0.1% TFA/80% acetonitrile for subsequent nanoLC-MS/MS analysis.
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NanoLC-Ms system. NanoLC-MS/MS analyses were performed using an Orbitrap system (LTQ-Orbitrap 
XL, Thermo Fisher Scientific, Rockwell, IL), a Dionex Ultimate 3000 pump with FLM-3000 flow manager (Thermo 
Fisher Scientific) and an HTC-PAL autosampler (CTC Analytics, Zwingen, Switzerland) as previously reported14. In 
brief, ReproSil C18 materials (3 μm, Dr. Maisch, Ammerbuch, Germany) were packed into an ESI needle (150 mm 
length × 100 μm I.D., 6 μm opening) to prepare an analytical column65. The injection volume was 5 μL, and the flow 
rate was 500 nL/min. The mobile phases consisted of (A) 0.5% acetic acid and (B) 0.5% acetic acid and 80% ace-
tonitrile. A three-step linear gradient of 5% to 10% B in 5 min, 10% to 40% B in 60 min, 40% to 100% B in 1 min and 
100% B for 4 min was employed throughout this study. A spray voltage of 2400 V was applied. The MS scan range 
was m/z 300–1500. The top ten precursor ions were selected in the MS scan by the Orbitrap with R = 60,000 for MS/
MS scans and the ion trap in automated gain control (AGC) mode, where AGC values of 5.00 × 105 and 1.00 × 104 
were set for full MS and MS/MS, respectively. To minimize repetitive MS/MS scanning, a dynamic exclusion time 
was set at 20 sec with a repeat count of 1 and an exclusion list size of 500. The normalized CID was set as 35.0. A lock 
mass function was used to obtain constant mass accuracy during gradient analysis66. The MS raw data and analysis 
files have been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via 
the jPOST partner repository67 (https://jpostdb.org) with the data set identifier PXD011366.
Database searching. Database searching was performed as described57. In brief, Mass Navigator v1.2 
(Mitsui Knowledge Industry, Tokyo, Japan) with the default parameters for the LTQ-Orbitrap XL was used to 
create peak lists based on the recorded fragmentation spectra. When the intensity of an MS/MS product ion in 
the peak list file was smaller than 10 or 0.1% of that of the highest peak, the ions at the noise level were removed 
from the peak list. The m/z values of the precursor isotope peaks were converted to the corresponding monoiso-
topic peaks when the isotope peaks were selected as the precursor ions68. Peptides and proteins were identified 
by means of automated database searching using Mascot v2.3 (Matrix Science, London) against SwissProt release 
2010_11 (2-Nov-2010) with a precursor mass tolerance of 3 ppm, a fragment ion mass tolerance of 0.8 Da and 
strict trypsin specificity69 allowing for up to 2 missed cleavages. Carbamidomethylation of cysteine was set as a 
fixed modification, and oxidation of methionines, phosphorylation of serine, threonine and tyrosine, and [1H4, 
12C2]- or [2H4, 13C2] dimethylation of amino groups at the peptide N-terminus and in the lysine side chain were 
allowed as variable modifications.
Peptides were considered identified if the Mascot score was over the 95% confidence limit based on the ‘iden-
tity’ score of each peptide and if at least three successive y- or b-ions with a further two or more y-, b- and/or 
precursor-origin neutral loss ions were observed, based on the error-tolerant peptide sequence tag concept70. The 
peak area of identified phosphopeptide was integrated using Mass Navigator v1.2, and then the peak area ratio for 
kinase-treated to control sample was calculated. Peptides for which the peak area ratio was less than or equal to 2 
and incompletely modified peptides were rejected. Decoy database search using a randomized database created 
by a Mascot Perl script gave a 0–0.3% false-positive rate for identified peptides with these criteria. Phosphosite 
localization was evaluated by using an in-house Perl script to check for the presence of a site-determining ion 
combination57, and PTM scores were obtained with PhosCalc version 1.271.
extraction of phosphorylation motifs. Using the amino acid sequences of phosphopeptides that were 
increased more than 2-fold with kinase reactions, all proteins containing each peptide sequence were extracted 
from the SwissProt database. Then, phosphoacceptor-centered 13-amino-acid sequences were extracted from the 
matched protein sequences, and redundant sequences were removed. Phosphorylation motifs of each kinase were 
extracted using Motif-x (http://motif-x.med.harvard.edu/)51, in which the minimum number of motif occur-
rences was set to 10, the significance threshold was set to 10e-6 and the IPI Human Proteome Database was used 
as a background.
Classification of protein kinases. The wild-type protein kinases of which in vitro substrate peptides were 
more than 100 for STKs and 200 for TKs were classified based on in vitro substrate data by using Cluster 3.072. The 
data matrix for cluster analysis was generated according to the following rules: if phosphorylation of each site was 
observed by each kinase reaction, the numerical value was set as 1, and if not, 0. Hierarchical cluster analysis was 
performed using a correlation similarity metric and centroid linkage after centering the data by subtracting mean 
values for columns and arrays. The clustering data were visualized as circle dendrograms were generated using 
iTOL73, ignoring branch length.
phosphorylation stoichiometry. The kinase reaction mixture was divided into 2 aliquots, which were 
labeled with normal or 2H2, 13C-labeled formaldehyde as described above. The stable isotope-labeled mixtures 
were subjected to phosphopeptide enrichment using metal oxide chromatography as described above. The two 
fractions were mixed and desalted with a SDB-XC stage tip and then evaporated in a vacuum concentrator. The 
peptides were dissolved in 50 mM Tris-HCl (pH 8.0), and 2 units of TSAP was added. After incubation at 37 °C for 
60 min, the solution was desalted with a SDB-XC stage tip and evaporated in a vacuum concentrator. The residue 
was taken up in 10 μL of solution A for subsequent nanoLC-MSMS analysis.
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